IL-2 COMO PREDITOR DA PROGRESSÃO DAS LESÕES INTRAEPITELIAIS DO COLO UTERINO: REVISÃO DA LITERATURA
Palavras-chave:
Citocinas, Interleucina 2, lesão intraepitelial escamosa.Resumo
Introdução: O objetivo desta revisão foi avaliar a participação da interleucina (IL) 2 como coadjuvante na progressão das neoplasias intraepitelial do colo uterino. Descrição: Foram pesquisados em fontes de dados Medline (Pubmed), Scielo artigos relacionados ao tema publicados entre 1994 e 2020, selecionando-se apenas os relevantes. Discussão: São abordados conceitos, tipos de imunidade presentes e células que fazem parte deste processo imunológico. O mecanismo de ação pelo qual um antígeno é captado pelo Sistema Imunológico, sendo influenciado por este e, dividindo-se, assim, em subgrupos TH0, TH1 e TH2. A diminuição nas concentrações da IL-2 com aumento da concentração de IL-10 e, a mudança do perfil TH1 para TH2,pode se caracterizar como um agravante clinico em mulheres com lesão intraepitelial de alto grau em colo uterino .
Referências
REFERÊNCIAS BIBLIOGRÁFICAS
MINDIOLA R, CAULEJAS D, NUÑEZ-TROCONIS J, ARAUJO M, et al. Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix. Invest Clin. 2008;49(4):533-45.
HONG JH; KIM MK; LEE IH; KIM TJ; KWAK SH; SONG SH; LEE JK. Association between serum cytokine profiles and clearance of persistence of high-risk human papillomavirus infection: a prospective study. Int J Gynecol Cancer. 2010 Aug;20(6):1011-6
MOSAFFA F; KALALINIA F; LAGE H; AFSHARI JT; BEHRAVAN J.Pro-inflammatory cytokines nand function of ABCG2 in cervix and gastric cancer cells. Mol Cell Biohem.2012 Apr;363(1-2):385-93
CAROZZI FM; TORNESELLO ML; BURRONI E; LOQUERCIO G; CARILLO G; ANGELINI C; SCALISI A; MACIS R; CHINI F; BUONAGURO FM; GIORGI ROSSI P; HPV Prevalence Italian Working Group.Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and câncer in Italy. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2389-400
MITELMAN AK, BUCCHERI V, PRACCHIA LF, RUBENS CV, POPPE S, et al.Quantificação das citocinas séricas TH1/TH2 por citometria de fluxo no linfoma de Hodgkin clássico. Rev .Bras.Hematol. Hemoter. 2009;31(4):260-266
ABBAS AK, LICHTMAN AH, PILLAI S. Imunologia – cellular e molecular.6 ed. Saunders Elsevier.2008 Rio de Janeiro-RJ.
YOON BS; KIM YT; KIM JW; KIM SH; KIM JH; KIM SW. Expression of human leukocytes antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet. 2007 jul;98(1):48-53
PETRY KU, SCHEFFEL D, BODE U, GABRYSIAK T, KÔCHEL H, KUPSCH E, GLAUBITZ M, NIESERT S, KÜHNLE H, SCHEDEL I. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 1994 Jun 15;57(6):836-40
LINDSTRÖM AK, AAPLUND A, HELLBERG D. Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with especial reference to tumor suppressors, in CIN and normal cervical epithelium. Gynecol Oncol, 2011 Aug; 122(2):372-6
TORNESELLO ML; LOSITO S; BENINCASA G; FULCINITI F; BOTTI G; GREGGI S; BUONAGURO L; BUONAGURO FM. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol.2011 Apr; 121(1):32-42
GUMBI PP, JAUMDALLY SZ, SALKINDER AL, BURGERS WA, MKHIZE NN, et al. CD4 T cell depletion at the cervix during HIV infection is associated with accumulation of terminally differentiated T cell. J Virol. 2011;85(24):13333-41
PARDO-GOVEA T, CALLEJAS D, NUÑEZ-TRONCONIS J, ARAUJO M, et al. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF- alpha) and interleukins 2,4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report. Invest Clin. 2005;46(1):5-13.
JACOBS N, RENARD I, AL-SALEH W, HUBERT P, DOYEN J, et al. Distinct T cell subsets and cytokine production in cultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix. Am J Reprod Immunol. 2003;49(1):6-13
SYRJÄNEN S; NAUD P; SARIAN l; DERCHAIN S; ROTELI-MARTINS C; LONGATTO-FILHO A; TATTI S; BRANCA M; ERZEN M; HAMMES LS; COSTA S; SYRJÄNEN K. Immunosupressive cytokine interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort. Virchows Arch. 2009 Dec; 455(6):505-15
BENJAMINI, E; COICO, R; SUNCHINE, G. Imunologia. 4 ed. Guanabara Koogan. Rio de Janeiro. 2002. P.115.
GUMBI PP, NKWANYANA NN, BERE A, BURGERS WA, GRAY CM, WILIAMSON AL, HOFFMAN M, COETZEE D, DENNY L, PASSMORE JA. Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T – cell responses in the female genital tract during chronic HIV infection. Journal of Virology, Sep. 2008, 8529- 8536. v. 82, n.17
MCKINNON LR, NYANGA B, CHEGE D, IZULLA P, KIMANI M, HUIBNER S, GELMON l, BLOCK KE, CICALA C, ANZALA AO, ARTHOS J, KIMANI J, KAUAL R. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol. 2011 Dec 1;187(11):6032-42.
MINKOFF H; FELDMAN J; DEHOVITZ J; LANDESMAN S; BURK R.A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol.1998 May; 178(5):982-6
SCOTT ME;MAa Y; KUZMICH L; MOSCICKI AB. Diminished IFN-? and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int J Cancer.2009 March 15;124(6):1379-1383
MATSUMOTO K, OKI A, SATOH T, OKADA S, MINANGUCHI T, ONUKI M, OCHI H, NAKAO S, SAKURAI M, ABE A, HAMADA H, YOSHIKAWA H. Interleukin- 10 – 1082 Gene polymorphism and susceptibility to cervical cancer among japaneses women. Jpn J Clin Oncol 2010; 40(11) 1113-1116
MKHIZE NN; GUMBI PP; LIEBENBERG LJ; REN Y; SMITH P; DENNY l; PASSMORE JAS. Persistence of genital tract T cell responses in HIV- infected women on highly active antiretroviral therapy. Journal of Virology, Oct.2010. 10765-10772 v.84, n.20
LINDSTRÖM AK, ASPLUND A, HELLBERG D. Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with especial reference to tumor suppressors, in CIN and normal cervical epithelium. Gynecol Oncol, 2011 Aug; 122(2):372-6
KOBAYASHI U, WEINBERG V, DARRAGH T, SMITH-McCUNE K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008 Sep; 1(5):412-20
SAMIR R, ASPLUND A, TOT T, PEKAR G, HELLBERG D. Tissue tumor marker expression in smokers, including serum cotinine concentrations, in women with cervical intraepithelial neoplasia or normal squamous cervical epithelium. Am J Obstet Gynecol. 2010 Jun; 202(6): 579.e 1-7.
SHARMA A, RAJAPPA M, SAXENA A, SHARMA M. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer. 2007 Jul-Aug; 17(4):879-85.
CLERICI M, MEROLA M, FERRARIO E, TRABATTONI D, VILLA ML, et al. Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection. J Natl Cancer Inst. 1997 Feb 5;89(3):245-50.
ROLLENHAGEN C; ASIN SN. Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses. Mucosal Immunol. 2011 Nov;4(6):671-81
YIN MC; LIN CC; WU HC; TSAO SM; HSU CK.Apoptotic effects of protocatechuic acid in human breatst, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. JAgric Food Chem.2009 jul 22;57(14):6468-73
ASIN SN; ESTERHAS SK; ROLLENHAGEN C; HEIMBERG AM; HOWELL AL.HIV type 1 infection in women: Increased transcription of HIV type 1 in ectocervical tissue explants. The Journal of Infectious Diseases.2009;200:965-72
AL-TAHHAN MA, ETEWA RL, El BEHERV MM. Association between circulating interleukin – 1 beta (IL-1?) levels and IL-1? C -511 T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem. 2011 Jul; 353(1-2):159-65
COCCO E, VARUGHESE J, BUZA N, BELLONE S, GLASGOW M, et al. Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: Implications for immunotherapy with Hi-con 1, a factor VII-IgGFc chimeric protein targetint tissue factor. BMC Cancer, 2011;11:263
SONG SH, LEE JK, SEOK OS, SAW HS. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Gynecol Oncol. 2007 Mar;104(3):732-8.
SONG SH; LEE JK; LEE NW; SAW HS; KANG JS; LEE KW. Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillommavirus (HPV). Gyecol Oncol. 2008 mar; 108(3):543-8
OLAITAN A; JOHNSON MA; REID WM; POULTER LW. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol 1998; 112:100-104
AL –SALEH W, GIANNINI SL, JACOBS N, MOUTSCHEN M, DOYEN J, et al. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol. 1998 mar;184(3):283-90.
GIANNINI SL, HUBERT P, DOYEN J, BONIVER J, DELVENNE P. Influence of the mucosal epithelium microenvironment on Langerhans cells: Implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer. 2002 feb;97(50:654-9.
LEE BN, FOLLEN M, SHEN DY, MALPICA A, STORTHZ KA, et al. Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions. Clin Diagn Lab Immunol. 2004 mar;11(2):239-44
LI B, ZHANG L, ZHAO J, TAN G, ZHANG W, ZHANG N, TIAN J, QU P. The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cérvix. Infect Agent Cancer. 2019 Jun 28;14:16. doi: 10.1186/s13027-019-0231-z. eCollection 2019.
ZHANG J, ZHANG D, YANG Z, WANG X, WANG D. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. BMC Cancer. 2020 May 19;20(1):443. doi: 10.1186/s12885-020-06935-w
GU L, HONG Z, GAO H, QIU L, DI W. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype. Cytopathology. 2019 Jul;30(4):419-425. doi: 10.1111/cyt.12717.
RANGER R, ROCHA L, RAMIREZ JL, IBARRA MJ, SOLORZA G, MONROY A, RAMIREZ MA, HERRERA A, WEISS-STEIDER B. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Eur Cytokine Netw. 1995 May-Jun;6(3):195-202. PMID: 8589277.
ZHANG J, JIN S, LI X, LIU L, XI L, WANG F, ZHANG S. Human Papillomavirus Type 16 Disables the Increased Natural Killer Cells in Early Lesions of the Cervix. J Immunol Res. 2019 Apr 28;2019:9182979. doi: 10.1155/2019/9182979. PMID: 31183395; PMCID: PMC6512046.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Arquivos Catarinenses de Medicina
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
